Brokers' take
Singapore Medical Group (SMG) > Buy (upgraded) RHB Research Institute, June 7 June 7 close: S$0.38 Target price: S$0.48
AS of Thursday's close, SMG's share price has fallen by 15 per cent to S$0.38 from S$0.445 since May 10. SMG's stock had a one-year return of -22.4 per cent.
The share price fell due to recent market sentiment, coupled with SMG's higher operating cost as a result of its ongoing expansion plan. Another overhang could be the price disparity between the conversion price (at S$0.423/share) of the convertible loan, and the sale of vendor shares (at S$0.605/share), which may have raised some concerns on minority shareholders' interests.
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Glencore-backed group said near deal for Shell Singapore assets
Chinese share of French EV market slumps after incentives curbed
ARA H-Trust Q1 net property income up marginally to US$6.4 million
HSBC has no plans to dispose of further businesses, chairman says
JPMorgan unveils IndexGPT in next Wall Street bid to tap AI boom
Morgan Stanley, Frasers settle UK lawsuit over US$1 billion margin call